Patents Assigned to Sylvan Pharmaceuticals Pty Ltd.
  • TREATMENT OF PRION PROTEIN RELATED DISEASES
    Publication number: 20140308272
    Abstract: According to the present invention, treatment of prion protein related diseases, and in particular cancer tumours, is effected by providing to a subject in need thereof a therapeutically effective amount of an agent capable of modulating binding of a prion protein and/or a prion-like protein to a disease related GAG and/or HSPG.
    Type: Application
    Filed: January 17, 2014
    Publication date: October 16, 2014
    Applicant: Sylvan Pharmaceuticals Pty, Ltd.
    Inventors: John Fergus McEwan, David Cullis-Hill, Martin Lyndale Windsor
  • INHIBITION OF CATHEPSIN K ACTIVITY AND THE TREATMENT AND PREVENTION OF DISEASE
    Publication number: 20130102562
    Abstract: The present invention provides a candidate compound that is suitable for use in methods of treating animals (preferably mammals) and in the preparation of a medicament, wherein the candidate compound down regulates Cathepsin K activity.
    Type: Application
    Filed: October 11, 2012
    Publication date: April 25, 2013
    Applicant: SYLVAN PHARMACEUTICALS PTY LTD.
    Inventor: Sylvan Pharmaceuticals Pty Ltd.
  • Inhibition of cathepsin K activity and the treatment and prevention of disease
    Patent number: 8293722
    Abstract: The present invention provides a candidate compound that is suitable for use in methods of treating animals (preferably mammals) and in the preparation of a medicament, wherein the candidate compound down regulates Cathepsin K activity.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: October 23, 2012
    Assignee: Sylvan Pharmaceuticals Pty Ltd.
    Inventors: David Cullis-Hill, Robert Logan Hannon, Christopher Bond Little, Margaret Mary Smith
  • INHIBITION OF CATHEPSIN K ACTIVITY AND THE TREATMENT AND PREVENTION OF DISEASE
    Publication number: 20090111771
    Abstract: The present invention provides a candidate compound that is suitable for use in methods of treating animals (preferably mammals) and in the preparation of a medicament, wherein the candidate compound down regulates Cathepsin K activity.
    Type: Application
    Filed: December 8, 2008
    Publication date: April 30, 2009
    Applicant: Sylvan Pharmaceuticals Pty. Ltd. CAN 102 641 332
    Inventors: David Cullis-Hill, Robert Logan Hannon, Christopher Bond Little, Margaret Mary Smith
  • Inhibition of cathepsin K activity and the treatment and prevention of disease
    Publication number: 20080076723
    Abstract: The present invention provides a candidate compound that is suitable for use in methods of treating animals (preferably mammals) and in the preparation of a medicament, wherein the candidate compound down regulates Cathepsin K activity.
    Type: Application
    Filed: September 27, 2006
    Publication date: March 27, 2008
    Applicant: Sylvan Pharmaceuticals Pty Ltd.
    Inventors: David Cullis-Hill, Robert Logan Hannon, Christopher Bond Little, Margaret Mary Smith